Approach
How we work
We work downstream, at the intersection of pharmaceutical companies and healthcare providers. That stance shapes everything: the questions we ask, the people we involve, and what we are willing to claim.
Between the two, where the work is unowned
Advisers to pharma stop at the hospital entrance. Advisers to the health system rarely understand a launch or the commercial realities of big pharma. The work that decides whether a product's forecast is realised happens between the two, and there is rarely a single clear owner of this challenge in pharmaceutical companies. We own it. We sit with the local team, as a partner to the system, sharing the goal of realising forecast benefit, not selling a report from outside and not pushing product. That difference is the point of the practice.
The method
Diagnose. Equip. Hand over. Stay alongside.
One method, behavioural-science led. We build the change with the team that has to live with it, then step back, and stay on for the moments that matter.
01
Diagnose
The real barrier inside the hospital or clinic, not the assumed one, evidenced before anything is designed.
02
Equip
The client's teams, with the tools and skills to remove it, built so the new way of working sticks.
03
Hand over
The method lives in the tools we hand over to you and the capability we develop in the local team.
04
Stay alongside
Things change. The health system, local team members, product uses and delivery mechanisms. We provide ongoing support for the moments where adoption is won or lost.
What stays constant, and what flexes
The method, the tools and the quality bar stay constant across engagements. What flexes is the team, assembled for the work in hand from people who have done it, not just advised on it. That is how a specialist practice delivers senior-level quality across multiple markets. Our contribution is therefore clear and measurable: we take credit only for the value we can demonstrably add, never for the entire outcome.
Next
Start a conversation.
A first conversation is a working session, not a pitch: the product, the shift in delivery it depends on, and where adoption is sticking.
Start a conversation